Grace Therapeutics (GRCE) Assets (2017 - 2026)
Grace Therapeutics (GRCE) recorded Assets of $50.07 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 28.3% from $69.81 million a year earlier and down 24.9% from the prior quarter.
Grace Therapeutics (GRCE) Assets (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Assets of $66.65 million, down 7.4% from FY2025.
- Annual Assets has declined for four straight fiscal years, though with a five-year compound annual growth rate of 1.3% (FY2021 to FY2026).
- Across earlier fiscal years, Assets came in at $71.99 million in FY2025 (-1.8%), $73.3 million in FY2024 (-7.4%), $79.12 million in FY2023 (-38.5%) and $128.62 million in FY2022 (+105.9%).
- The fiscal Q1 2027 figure is the lowest quarterly Assets since fiscal Q3 2021.
- On a year-over-year basis, Assets rose in three of the last eight quarters, with an average decline of 7.5%.
- Peak year-over-year performance for Assets in the last five years was growth of 766.1% in fiscal Q2 2022, against a decline of 41.5% in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $66.65 million (Q4 2026), $68.49 million (Q3 2026) and $66.58 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 50.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.07 Mn |
| Mar 31, 2026 | 66.65 Mn |
| Dec 31, 2025 | 68.49 Mn |
| Sep 30, 2025 | 66.58 Mn |
| Jun 30, 2025 | 69.81 Mn |
| Mar 31, 2025 | 71.99 Mn |
| Dec 31, 2024 | 61.22 Mn |
| Sep 30, 2024 | 65.35 Mn |
| Jun 30, 2024 | 69.72 Mn |
| Mar 31, 2024 | 73.30 Mn |
| Dec 31, 2023 | 76.19 Mn |
| Sep 30, 2023 | 78.21 Mn |
| Jun 30, 2023 | 73.03 Mn |
| Mar 31, 2023 | 79.12 Mn |
| Dec 31, 2022 | 116.80 Mn |
| Sep 30, 2022 | 120.91 Mn |
| Jun 30, 2022 | 124.93 Mn |
| Mar 31, 2022 | 128.62 Mn |
| Dec 31, 2021 | 114.23 Mn |
| Sep 30, 2021 | 119.80 Mn |
Grace Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();